September 2024 in “Archives of Medical Science” The study analyzed immune-related biomarkers in alopecia areata (AA) by examining expression data from 60 individuals with AA and 36 controls, identifying 1,708 IncRNAs and 17,326 mRNAs, with 427 differentially expressed regions. It highlighted the autoimmune nature of AA, noting significant differences in T cell subtypes and identifying CXCL9 and CXCL10 as key prognostic factors with high diagnostic potential (AUC values of 0.87 and 0.836). The research also pointed to other biomarkers like IncRNAs MIR155HG and TSPOAP1-AS1, and genes CCL13 and IL21R, suggesting their roles in AA progression. These findings underscore the importance of T cell subsets and specific chemokines in AA, proposing potential targets for new therapies and emphasizing the need for further validation in larger cohorts.
April 2019 in “Journal of Investigative Dermatology” The humanized AA mouse model is better for testing new alopecia areata treatments.
107 citations
,
October 2022 in “Frontiers in Immunology” T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.
January 2024 in “Inflammation and regeneration” Th22 cells are essential for Tβ15-induced hair growth in mice.
March 2024 in “Frontiers in genetics” Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.